Does my Health Insurance Plan cover Weight Loss Medications?
Updated March 16, 2026
If you are one of the roughly 40 percent of Americans living with obesity, chances are you have heard of or considered treatment with anti‑obesity medications (AOMs).
Obesity is a relapsing, chronic disease that is affected by genetics, lifestyle, environment and sleep. Body weight is defended by a complex communication pathways between the brain, digestive system and fat cells. And while diet and exercise play a major role in obesity, studies have suggested that many people cannot lose weight long-term with lifestyle changes alone..
Anti‑obesity medications are drugs that promote weight loss by suppressing appetite, controlling cravings or altering metabolic signals. These drugs work best in combination with lifestyle changes, such as healthier eating, added physical activity and improved sleep.
Medications that are currently FDA-approved for weight loss include:
Orlistat (Xenical, Alli)
Phentermine (Adipex)
Bupropion‑Naltrexone (Contrave)
Phentermine‑Topiramate (Qsymia)
Liraglutide (Saxenda)
Semaglutide (Wegovy)
Tirzepatide (Zepbound)
Depending on the medication, patients typically lose about 5 to 22 percent of their body weight. Even modest weight loss can have a profound impact on health, improving conditions such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnea and mobility. Because obesity is chronic disease, AOMs are intended to be used long‑term.
Insurance coverage of AOMs has shifted in the past few years. Some plans that once covered AOMs have cut benefits. Others limit coverage to a very narrow list of diagnoses. Increasingly, many employers only cover obesity medications when they are prescribed through specific third-party programs they contract with.
Medicare still does not cover anti-obesity medications for weight loss because they are classified as non-covered drugs. However, some GLP-1 medications now have FDA approval for conditions beyond weight loss, such as cardiovascular risk reduction with Wegovy and treatment of obstructive sleep apnea with Zepbound. Medicare coverage may be available when these medications are prescribed for those specific conditions, but not for weight loss alone.
Most state Medicaid programs do not cover AOMs, although a few are updating their policies. New York Medicaid generally does not cover medications for weight loss, but Wegovy may be covered in limited cases for patients who have all three of the following: established cardiovascular disease, BMI ≥ 40 and documented lifestyle modification.
Private insurance varies widely in what it covers, what diagnoses trigger coverage, and what prior authorization requirements must be met.
What this could potentially mean for you:
Coverage can change when you switch jobs or plans.
A drug covered last year might not be covered this year or it may need a specific diagnosis code.
Coverage may also depend on your employer’s benefit rules. Some employers only cover obesity medications when they are prescribed through specific contracted programs, even if other doctors are in-network with your insurance.
To navigate coverage:
Know your health status. Work with your medical provider to calculate your body mass index (BMI) and document comorbidities. Insurers use this to decide eligibility.
Check your policy details. Review the explanation of benefits online or call customer service. Ask which anti‑obesity drugs are covered, what diagnostic criteria are required, whether prior authorization is needed, how long coverage lasts and your estimated out‑of‑pocket cost.
Some health plans exclude coverage all obesity medications (e.g. Medicaid and Medicare). If you have an employer-sponsored commercial health insurance with an exclusion for obesity medications, consider advocating to change this with your employer’s human resources department.
Work with an obesity medicine doctor to choose the right medication for you and to help with prior authorization paperwork. If your plan won’t cover branded AOMs, they may help explore alternatives or patient assistance programs.